Liothyronine – House of Lords
Case Details with Clear Evidence that NHS England Guidance on Prescription of Liothyronine is not Being Followed by CCGs
Evidence in Response to a Request from The Lord O’Shaughnessy Parliamentary Under-Secretary of State for Health and Social Care
Report dated 19 October 2018
Thyroid Patient Advocacy was one of the contributing authors
Download the report below
LIOTHYRONINE CASE EVIDENCE DOSSIER FINAL Approved 19 October 2018
You must be logged in to post a comment.
Previous comments
Your comment has been removed.
Please do not use the comment facility for unsolicited advertising.
TPA Admin